Serious adverse events pancreatitis, gallbladder disease, hypoglycemia in patients on concurrent insulin secretagogues are class effects of GLP-1 receptor agonists and apply equally across all three forms
In the treatment-adherent analysis, covering people who completed the full 64 weeks on treatment, oral semaglutide 25mg produced an average weight loss of 16.6%, compared with 2.7% for placebo
He said those who were already taking semaglutide will not be retroactively required to use Intellihealth, but he is looking at incentives so people will voluntarily join the program
Oral Incretins: The convenience of oral administration is a major draw, and several companies, including Lilly (orforglipron) and Structure Therapeutics (GSBR-1290) , are developing oral small molecule GLP-1 receptor agonists that could offer a more accessible option
Its like giving your antioxidant system a direct infusion of what it needs, rather than waiting for the body to build it up